L-type calcium channels: asymmetrical intramembrane binding domain revealed by variable length, permanently charged 1,4-dihydropyridines

R Bangalore, N Baindur, A Rutledge, DJ Triggle and RS Kass

Department of Physiology, University of Rochester School of Medicine and Dentistry, New York 14642-8642.

We have used an homologous series of dihydropyridine (DHP) derivatives to determine the location of the binding domain for DHPs on cardiac L- type calcium channels, relative to the extracellular and intracellular membrane surfaces. The series of test molecules consisted of DHP analogs in which the DHP moiety was linked to either a neutral (- CH2CH3) or permanently charged [(-)+N(CH3)3] headgroup and the distance between the headgroup and the active moiety was systematically varied with alkyl spacer chains containing 2, 6, 8, 10, 12, or 16 methylene (- CH2) groups. These compounds were previously shown, by radioligand binding experiments, to interact with the high affinity DHP binding site in intact neonatal rat heart cells. In the present experiments, access to the DHP binding site was assayed by inhibition of L-type calcium channel currents using whole-cell patch-clamp procedures in guinea pig ventricular myocytes. Intracellular application was achieved by dialysis via charged DHP-containing whole-cell patch pipettes, and cell dialysis was monitored by using a charged DHP labeled with a rhodamine fluorophore. Our results show that access of extracellularly applied charged, but not neutral, DHPs to the DHP binding domain depends markedly on the alkyl spacer chain, with the optimal length being near 10 methylene groups. Intracellular application failed to inhibit channel activity for spacer chain lengths up to 16 methylene groups. From our results, we conclude that the DHP binding domain of cardiac L-type calcium channels is not on the extracellular membrane surface but is probably within the lipid bilayer, approximately 11-14 A from the extracellular surface.

Volume 46, Issue 4, pp. 660-666, 10/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				M. Hirasawa and Q. J. Pittman From the Cover: Nifedipine facilitates neurotransmitter release independently of calcium channels PNAS, May 13, 2003; 100(10): 6139 - 6144. [Abstract] [Full Text] [PDF]

				G. M. Lipkind and H. A. Fozzard Molecular Modeling of Interactions of Dihydropyridines and Phenylalkylamines with the Inner Pore of the L-Type Ca2+ Channel Mol. Pharmacol., March 1, 2003; 63(3): 499 - 511. [Abstract] [Full Text] [PDF]

				P. P. Kumar, S. C. Stotz, R. Paramashivappa, A. M. Beedle, G. W. Zamponi, and A. S. Rao Synthesis and Evaluation of a New Class of Nifedipine Analogs with T-Type Calcium Channel Blocking Activity Mol. Pharmacol., March 1, 2002; 61(3): 649 - 658. [Abstract] [Full Text] [PDF]

				J.-B. Shen, B. Jiang, and A. J. Pappano Comparison of L-Type Calcium Channel Blockade by Nifedipine and/or Cadmium in Guinea Pig Ventricular Myocytes J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 562 - 570. [Abstract] [Full Text]

				L. Lacinová, R. H. An, J. Xia, H. Ito, N. Klugbauer, D. Triggle, F. Hofmann, and R. S. Kass Distinctions in the Molecular Determinants of Charged and Neutral Dihydropyridine Block of L-Type Calcium Channels J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1472 - 1479. [Abstract] [Full Text]

				S. Gaur, M. E. Morton, G. P. Frick, and H. M. Goodman Growth hormone regulates the distribution of L-type calcium channels in rat adipocyte membranes Am J Physiol Cell Physiol, August 1, 1998; 275(2): C505 - C514. [Abstract] [Full Text] [PDF]

				G. H. Hockerman, B. Z. Peterson, E. Sharp, T. N. Tanada, T. Scheuer, and W. A. Catterall Construction of a high-affinity receptor site for dihydropyridine agonists and antagonists by single amino acid substitutions in a non-L-type Ca2+ channel PNAS, December 23, 1997; 94(26): 14906 - 14911. [Abstract] [Full Text] [PDF]

				B. Z. Peterson, B. D. Johnson, G. H. Hockerman, M. Acheson, T. Scheuer, and W. A. Catterall Analysis of the Dihydropyridine Receptor Site of L-type Calcium Channels by Alanine-scanning Mutagenesis J. Biol. Chem., July 25, 1997; 272(30): 18752 - 18758. [Abstract] [Full Text] [PDF]

				N. M. Soldatov, R. D. Zuhlke, A. Bouron, and H. Reuter Molecular Structures Involved in L-type Calcium Channel Inactivation. ROLE OF THE CARBOXYL-TERMINAL REGION ENCODED BY EXONS 40-42 IN alpha 1C SUBUNIT IN THE KINETICS AND Ca2+ DEPENDENCE OF INACTIVATION J. Biol. Chem., February 7, 1997; 272(6): 3560 - 3566. [Abstract] [Full Text] [PDF]

				J. Kurokawa, S. Adachi-Akahane, and T. Nagao 1,5-Benzothiazepine Binding Domain Is Located on the Extracellular Side of the Cardiac L-Type Ca2+ Channel Mol. Pharmacol., February 1, 1997; 51(2): 262 - 268. [Abstract] [Full Text] [PDF]

				L. A. Smith, X. Wang, A. A. Peixoto, E. K. Neumann, L. M. Hall, and J. C. Hall A Drosophila Calcium Channel alpha 1 Subunit Gene Maps to a Genetic Locus Associated with Behavioral and Visual Defects J. Neurosci., December 15, 1996; 16(24): 7868 - 7879. [Abstract] [Full Text] [PDF]

				B. Z. Peterson, T. N. Tanada, and W. A. Catterall Molecular Determinants of High Affinity Dihydropyridine Binding in L-type Calcium Channels J. Biol. Chem., March 8, 1996; 271(10): 5293 - 5296. [Abstract] [Full Text] [PDF]

				R.H. An, M.P. Davies, P.A. Doevendans, S.W. Kubalak, R. Bangalore, K.R. Chien, and R.S. Kass Developmental Changes in ß-Adrenergic Modulation of L-Type Ca2+ Channels in Embryonic Mouse Heart Circ. Res., March 1, 1996; 78(3): 371 - 378. [Abstract] [Full Text]

				S. Yamaguchi, Y. Okamura, T. Nagao, and S. Adachi-Akahane Serine Residue in the IIIS5-S6 Linker of the L-type Ca2+ Channel alpha 1C Subunit Is the Critical Determinant of the Action of Dihydropyridine Ca2+ Channel Agonists J. Biol. Chem., December 22, 2000; 275(52): 41504 - 41511. [Abstract] [Full Text] [PDF]